Labahn J, Neumann S, Buldt G, Kula MR, Granzin J (2002) An alternative mechanism for amidase signature enzymes. J Mol Biol 322: 1053-1064

Lacinova L (2004) Pharmacology of recombinant low-voltage activated calcium channels. Curr Drug Target CNS Neurol Disord 3: 105-111

Lagalwar S, Bordayo EZ, Hoffmann KL, Fawcett JR, Frey WH, 2nd (1999) Anandamides inhibit binding to the muscarinic acetylcholine receptor. J Mol Neurosci 13: 55-61

Lagneux C, Adam A, Lamontagne D (2003) A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart. Int Immunopharmacol 3: 1511-1518

Lagneux C, Lamontagne D (2001) Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br J Pharmacol 132: 793-796

Lagu SG, Varona A, Chambers JD, Reggio PH (1995) Construction of a steric map of the binding pocket for cannabinoids at the cannabinoid receptor. Drug Des Discov 12: 179-192

Lai FA, Anderson K, Rousseau E, Liu QY, Meissner G (1988) Evidence for a Ca2+ channel within the ryanodine receptor complex from cardiac sarcoplasmic reticulum. Biochem Biophys Res Commun 151: 441-449

Laine K, Jarvinen K, Mechoulam R, Breuer A, Jarvinen T (2002) Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. Invest Ophthalmol Vis Sci 43: 3216-3222

Laine K, Jarvinen K, Pate DW, Urtti A, Jarvinen T (2002) Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides. Invest Ophthalmol Vis Sci 43: 393-397

Laine K, Jarvinen T, Savinainen J, Laitinen JT, Pate DW, Jarvinen K (2001) Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. Pharm Res 18: 494-499

Lake KD, Compton DR, Varga K, Martin BR, Kunos G (1997) Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281: 1030-1037

Lake KD, Martin BR, Kunos G, Varga K (1997) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29: 1204-1210

Lallemand F, Soubrie PH, De Witte PH (2001) Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin Exp Res 25: 1317-1323

Lam HH, Bhardwaj A, O'Connell MT, Hanley DF, Traystman RJ, Sofroniew MV (1998) Nerve growth factor rapidly suppresses basal, NMDA-evoked, and AMPA-evoked nitric oxide synthase activity in rat hippocampus in vivo. Proc Natl Acad Sci U S A 95: 10926-10931

Lambert DM, Di Marzo V (1999) The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 6: 757-773

Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, Bueb J, Delzenne NM, Tschirhart EJ (1999) Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta 1440: 266-274

Lambert DM, Vandevoorde S, Diependaele G, Govaerts SJ, Robert AR (2001) Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 42: 321-327

Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 9: 663-674

Lan R, Gatley J, Lu Q, Fan P, Fernando SR, Volkow ND, Pertwee R, Makriyannis A (1999) Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS PharmSci 1: E4

Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42: 769-776

Landa L, Sulcova A, Slais K (2003) Pretreatment with cannabinoid receptor agonist and antagonist increases and decreases, respectively, sensitization to methamphetamine stimulation of mouse locomotor behaviour. Behavioural Pharmacology 14

Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI (1997) SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol 334: R1-2

Landsman RS, Makriyannis A, Deng H, Consroe P, Roeske WR, Yamamura HI (1998) AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Life Sci 62: PL109-113

Lang W, Qin C, Hill WA, Lin S, Khanolkar AD, Makriyannis A (1996) High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes. Anal Biochem 238: 40-45

Lang W, Qin C, Lin S, Khanolkar AD, Goutopoulos A, Fan P, Abouzid K, Meng Z, Biegel D, Makriyannis A (1999) Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J Med Chem 42: 896-902

Lange JH, Coolen HK, van Stuivenberg HH, Dijksman JA, Herremans AH, Ronken E, Keizer HG, Tipker K, McCreary AC, Veerman W, Wals HC, Stork B, Verveer PC, den Hartog AP, de Jong NM, Adolfs TJ, Hoogendoorn J, Kruse CG (2004) Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists. J Med Chem 47: 627-643

Langstein J, Hofstadter F, Schwarz H (1996) cis-9,10-octadecenoamide, an endogenous sleep-inducing CNS compound, inhibits lymphocyte proliferation. Res Immunol 147: 389-396

Lanoue A, Batista FD, Stewart M, Neuberger MS (2002) Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur J Immunol 32: 348-355

Laskey RA, Gorlich D, Madine MA, Makkerh JP, Romanowski P (1996) Regulatory roles of the nuclear envelope. Exp Cell Res 229: 204-211

Lastres-Becker I, Berrendero F, Lucas JJ, Martin-Aparicio E, Yamamoto A, Ramos JA, Fernandez-Ruiz JJ (2002) Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Res 929: 236-242

Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Brouillet E, Fernandez-Ruiz J (2003) Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate. Neuroreport 14: 813-816

Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernandez-Ruiz JJ (2001) Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. Eur J Neurosci 14: 1827-1832

Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernandez-Ruiz J (2003) Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. J Neurochem 84: 1097-1109

Lastres-Becker I, De Miguel R, Fernandez-Ruiz JJ (2003) The endocannabinoid system and Huntington's disease. Curr Drug Target CNS Neurol Disord 2: 335-347

Lastres-Becker I, Fezza F, Cebeira M, Bisogno T, Ramos JA, Milone A, Fernandez-Ruiz J, Di Marzo V (2001) Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport 12: 2125-2129

Lastres-Becker I, Gomez M, De Miguel R, Ramos JA, Fernandez-Ruiz J (2002) Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease. Neurotox Res 4: 601-608

Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Perez-Rosado A, Manzanares J, Ramos JA, Fernandez-Ruiz J (2002) Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse 44: 23-35

Lastres-Becker I, Manzanares J, Hansen HH, Berrendero F, de Miguel R, Perez-Rosado A, Ramos JA, Fernandez-Ruiz JJ (2000) Am404, an inhibitor of the endocannabinoid uptake, attenuated motor hyperactivity in a rat model of huntington's disease. Society for Neuroscience Abstracts 26: Abstract No.-480.489

Lau AH, Chow SS (2003) Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. Eur J Pharmacol 464: 229-235

Lau LF, Mammen A, Ehlers MD, Kindler S, Chung WJ, Garner CC, Huganir RL (1996) Interaction of the N-methyl-D-aspartate receptor complex with a novel synapse-associated protein, SAP102. J Biol Chem 271: 21622-21628

Lawrence AD, Calder AJ, McGowan SW, Grasby PM (2002) Selective disruption of the recognition of facial expressions of anger. Neuroreport 13: 881-884

Lawrence DS, Zilfou JT, Smith CD (1999) Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem 42: 4932-4941

Lawrence N, Klein T, Brennan K, Martinez Arias A (2000) Structural requirements for notch signalling with delta and serrate during the development and patterning of the wing disc of Drosophila. Development 127: 3185-3195

Lay L, Angus JA, Wright CE (2000) Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Eur J Pharmacol 391: 151-161

Le Maire M, Wins P (1972) Some properties of particulate ATPases and phosphatases isolated from the harderian gland of the duck. Arch Int Physiol Biochim 80: 423-441

Le Novere N, Changeux JP (2001) The Ligand Gated Ion Channel database: an example of a sequence database in neuroscience. Philos Trans R Soc Lond B Biol Sci 356: 1121-1130

Lechleiter JD, Dartt DA, Brehm P (1988) Vasoactive intestinal peptide activates Ca2(+)-dependent K+ channels through a cAMP pathway in mouse lacrimal cells. Neuron 1: 227-235

Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404

Ledermann C, Lavand'Homme P, De Kock M, Vandevoorde S, Lambert D (2002) Activation of Endocannabinoid System Reduces Opioid-Induced Hyperalgesia. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002

Lee JR, Urban S, Garvey CF, Freeman M (2001) Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila. Cell 107: 161-171

Lee K, Dixon AK, Gonzalez I, Stevens EB, McNulty S, Oles R, Richardson PJ, Pinnock RD, Singh L (1999) Bombesin-like peptides depolarize rat hippocampal interneurones through interaction with subtype 2 bombesin receptors. J Physiol 518 (Pt 3): 791-802

Lee K, Dixon AK, Richardson PJ, Pinnock RD (1999) Glucose-receptive neurones in the rat ventromedial hypothalamus express KATP channels composed of Kir6.1 and SUR1 subunits. J Physiol 515 (Pt 2): 439-452

Lee LY, Shuei Lin Y, Gu Q, Chung E, Ho CY (2003) Functional morphology and physiological properties of bronchopulmonary C-fiber afferents. Anat Rec 270A: 17-24

Lee M, Yang KH, Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275: 529-536

Lee MC, Smith FL, Stevens DL, Welch SP (2003) The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 305: 593-599

Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948

Lee SF, Newton C, Widen R, Friedman H, Klein TW (2001) Downregulation of cannabinoid receptor 2 (CB2) messenger RNA expression during in vitro stimulation of murine splenocytes with lipopolysaccharide. Adv Exp Med Biol 493: 223-228

Lee YJ, Zachrisson O, Tonge DA, McNaughton PA (2002) Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons. Mol Cell Neurosci 19: 186-200

Lees G, Dougalis A (2004) Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. Brain Res 997: 1-14

Leggett JD, Aspley S, Beckett SR, D'Antona AM, Kendall DA (2004) Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 141: 253-262

Leiba H, Garty NB, Schmidt-Sole J, Piterman O, Azrad A, Salomon Y (1990) The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. Eur J Pharmacol 181: 71-82

Leite MF, Thrower EC, Echevarria W, Koulen P, Hirata K, Bennett AM, Ehrlich BE, Nathanson MH (2003) Nuclear and cytosolic calcium are regulated independently. Proc Natl Acad Sci U S A 100: 2975-2980

Lenhard JM, Furfine ES, Jain RG, Ittoop O, Orband-Miller LA, Blanchard SG, Paulik MA, Weiel JE (2000) HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. Antiviral Res 47: 121-129

Lepicier P, Bouchard JF, Lagneux C, Lamontagne D (2003) Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol 139: 805-815

Leroy S, Griffon N, Bourdel MC, Olie JP, Poirier MF, Krebs MO (2001) Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. Am J Med Genet 105: 749-752

Leung D, Hardouin C, Boger DL, Cravatt BF (2003) Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat Biotechnol 21: 687-691

Lever IJ, Malcangio M (2002) CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. Br J Pharmacol 135: 21-24

Levin M, Mercola M (1998) Gap junctions are involved in the early generation of left-right asymmetry. Dev Biol 203: 90-105

Levin M, Mercola M (2000) Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. Dev Dyn 219: 96-101

Levin MD, Shimizu TS, Bray D (2002) Binding and diffusion of CheR molecules within a cluster of membrane receptors. Biophys J 82: 1809-1817

Levine TP, Munro S (2001) Dual targeting of Osh1p, a yeast homologue of oxysterol-binding protein, to both the Golgi and the nucleus-vacuole junction. Mol Biol Cell 12: 1633-1644

Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10: 1665-1669

Lewis AJ, Wester TJ, Burrin DG, Dauncey MJ (2000) Exogenous growth hormone induces somatotrophic gene expression in neonatal liver and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 278: R838-844

Lewis MJ, Pelham HR (2002) A new yeast endosomal SNARE related to mammalian syntaxin 8. Traffic 3: 922-929

Li J, Bench AJ, Huntly BJ, Green AR (2001) Mutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia vera. Br J Haematol 115: 872-880

Li J, Derbyshire DJ, Promdonkoy B, Ellar DJ (2001) Structural implications for the transformation of the Bacillus thuringiensis delta-endotoxins from water-soluble to membrane-inserted forms. Biochem Soc Trans 29: 571-577

Li J, Forhead AJ, Dauncey MJ, Gilmour RS, Fowden AL (2002) Control of growth hormone receptor and insulin-like growth factor-I expression by cortisol in ovine fetal skeletal muscle. J Physiol 541: 581-589

Li J, Gilmour RS, Saunders JC, Dauncey MJ, Fowden AL (1999) Activation of the adult mode of ovine growth hormone receptor gene expression by cortisol during late fetal development. Faseb J 13: 545-552

Li J, Kaminski NE, Wang DH (2003) Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension 41: 757-762

Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK (2001) Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 86: 1823-1834

Liang YC, Huang CC, Hsu KS, Takahashi T (2004) Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices. J Physiol 555: 85-96

Lichtman AH, Cook SA, Martin BR (1996) Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 276: 585-593

Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl) 119: 282-290

Lichtman AH, Hawkins EG, Griffin G, Cravatt BF (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302: 73-79

Lichtman AH, Martin BR (2000) Does an endocannabinoid system tonically modulate nociception? Drug and Alcohol Dependence 60

Lichtman AH, Martin BR (2002) Marijuana withdrawal syndrome in the animal model. J Clin Pharmacol 42: 20S-27S

Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR (2001) The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend 63: 107-116

Lichtman AH, Varvel SA, Martin BR (2002) Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66: 269-285

Lichtman AH, Wiley JL, LaVecchia KL, Neviaser ST, Arthur DB, Wilson DM, Martin BR (1998) Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. Eur J Pharmacol 357: 139-148

Lietha D, Chirgadze DY, Mulloy B, Blundell TL, Gherardi E (2001) Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. Embo J 20: 5543-5555

Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'Argenio G, Scaglione G, Bifulco M, Sorrentini I, Di Marzo V (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125: 677-687

Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, Ortar G, Di Marzo V (2004) Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem J 380: 265-272

Lim HN, Chen H, McBride S, Dunning AM, Nixon RM, Hughes IA, Hawkins JR (2000) Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Mol Genet 9: 829-834

Lim HN, Nixon RM, Chen H, Hughes IA, Hawkins JR (2001) Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 86: 3207-3210

Lin GC, Rurangirwa JK, Koval M, Steinberg TH (2004) Gap junctional communication modulates agonist-induced calcium oscillations in transfected HeLa cells. J Cell Sci 117: 881-887

Lin MJ, Tan CT, Lee SY, Lin-Shiau SY (2000) Suramin protects the murine motor nerves from the toxic effects of presynaptic Ca(2+) channel inhibitors. Neurosci Lett 287: 97-100

Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A (1998) Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. J Med Chem 41: 5353-5361

Lin YH, Xu JL, Hu J, Wang LH, Ong SL, Leadbetter JR, Zhang LH (2003) Acyl-homoserine lactone acylase from Ralstonia strain XJ12B represents a novel and potent class of quorum-quenching enzymes. Mol Microbiol 47: 849-860

Lin YS, Lee LY (2002) Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. J Physiol 539: 947-955

Littleton-Kearney MT, Ostrowski NL, Cox DA, Rossberg MI, Hurn PD (2002) Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev 8: 309-330

Liu J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, Gao B, Kunos G (2003) Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J Biol Chem 278: 45034-45039

Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346 Pt 3: 835-840

Liu KJ, Nag A, Shaw JF (2001) Lipase-catalyzed synthesis of fatty acid diethanolamides. J Agric Food Chem 49: 5761-5764

Liu P, Bilkey DK, Darlington CL, Smith PF (2003) Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Brain Res 979: 235-239

Liu Q, Tonai T, Ueda N (2002) Activation of N-acylethanolamine-releasing phospholipase D by polyamines. Chem Phys Lipids 115: 77-84

Liu WM, Duan EK, Cao YJ (2002) Effects of anandamide on embryo implantation in the mouse. Life Sci 71: 1623-1632

Liu YC, Wu SN (2003) Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells. Eur J Pharmacol 458: 37-47

Llano I, Marty A (1987) Protein kinase C activators inhibit the inositol trisphosphate-mediated muscarinic current responses in rat lacrimal cells. J Physiol 394: 239-248

Llano I, Marty A, Tanguy J (1987) Dependence of intracellular effects of GTP gamma S and inositoltrisphosphate on cell membrane potential and on external Ca ions. Pflugers Arch 409: 499-506

Lo YK, Chiang HT, Wu SN (2003) Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells. Biochem Pharmacol 65: 581-591

Lockhart A, Davis B, Matthews JC, Rahmoune H, Hong G, Gee A, Earnshaw D, Brown J (2003) The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nucl Med Biol 30: 199-206

Lockwood CJ (2000) Prediction of pregnancy loss. Lancet 355: 1292-1293

Loewen PS (2002) Anti-emetics in development. Expert Opin Investig Drugs 11: 801-805

Lohi O, Urban S, Freeman M (2004) Diverse substrate recognition mechanisms for rhomboids; thrombomodulin is cleaved by Mammalian rhomboids. Curr Biol 14: 236-241

Long DA, Martin AJ (1956) Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guineapigs. Lancet 270: 464-466

Loomis-Husselbee JW, Walker CD, Bottomley JR, Cullen PJ, Irvine RF, Dawson AP (1998) Modulation of Ins(2,4,5)P3-stimulated Ca2+ mobilization by ins(1,3,4, 5)P4: enhancement by activated G-proteins, and evidence for the involvement of a GAP1 protein, a putative Ins(1,3,4,5)P4 receptor. Biochem J 331 (Pt 3): 947-952

Looms DK, Tritsaris K, Dissing S (2002) Nitric oxide-induced signalling in rat lacrimal acinar cells. Acta Physiol Scand 174: 109-115

Lopez-Redondo F, Lees GM, Pertwee RG (1997) Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br J Pharmacol 122: 330-334

Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fernandez-Ruiz J, Ramos JA (2002) Endocannabinoid transporter inhibitors. Current Medicinal Chemistry - Central Nervous System Agents 2: 129-141

Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, de Lago E, Fernandez-Ruiz J, Ramos JA (2003) Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. Eur J Med Chem 38: 403-412

Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, de Lago E, Fernandez-Ruiz J, Ramos JA (2003) Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J Med Chem 46: 1512-1522

Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Lastres-Becker I, Gonzalez S, Fernandez-Ruiz J, Ramos JA (2001) Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J Med Chem 44: 4505-4508

Losonczy A, Biro AA, Nusser Z (2004) Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A 101: 1362-1367

Love JD, Gooch JT, Nagy L, Chatterjee VK, Schwabe JW (2000) Transcriptional repression by nuclear receptors: mechanisms and role in disease. Biochem Soc Trans 28: 390-396

Lovinger DM (2002) mGluR-dependent striatal long-term synaptic depression involves an endocannabinoid retrograde messenger. Neuropharmacology 43: 296-296

Low LY, Hernandez H, Robinson CV, O'Brien R, Grossmann JG, Ladbury JE, Luisi B (2002) Metal-dependent folding and stability of nuclear hormone receptor DNA-binding domains. J Mol Biol 319: 87-106

Lu Q, Straiker A, Maguire G (2000) Expression of CB2 cannabinoid receptor mRNA in adult rat retina. Vis Neurosci 17: 91-95

Lu Q, Yang YT, Chen CS, Davis M, Byrd JC, Etherton MR, Umar A (2004) Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. J Med Chem 47: 467-474

Lu XR, Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in monkey basal forebrain. J Neurocytol 28: 1045-1051

Lu YC, Su W, Jiann BP, Chang HT, Huang JK, Jan CR (2002) Effect of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropy l) cyclohexanol (CP55,940) on intracellular Ca2+ levels in human osteosarcoma cells. Chin J Physiol 45: 95-100

Luhrs CA, Slomiany BL (1989) A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J Biol Chem 264: 21446-21449

Lui PP, Kong SK, Fung KP, Lee CY (1998) The rise of nuclear and cytosolic Ca2+ can be uncoupled in HeLa cells. Pflugers Arch 436: 371-376

Luo C, Kumamoto E, Furue H, Chen J, Yoshimura M (2002) Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin. Neurosci Lett 321: 17-20

Lutz B (2002) Molecular biology of cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids 66: 123-142

Luzio JP, Mullock BM, Pryor PR, Lindsay MR, James DE, Piper RC (2001) Relationship between endosomes and lysosomes. Biochem Soc Trans 29: 476-480

Lynch CJ, Fox H, Hazen SA, Stanley BA, Dodgson S, Lanoue KF (1995) Role of hepatic carbonic anhydrase in de novo lipogenesis. Biochem J 310 (Pt 1): 197-202